Recurrent glioblastoma multiforme: a review of natural history and management options.
about
The Efficacy of Ketogenic Diet and Associated Hypoglycemia as an Adjuvant Therapy for High-Grade Gliomas: A Review of the LiteratureClinical outcomes following salvage Gamma Knife radiosurgery for recurrent glioblastoma.External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastomaStrategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma.A nanoparticle carrying the p53 gene targets tumors including cancer stem cells, sensitizes glioblastoma to chemotherapy and improves survival.Thermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma modelCharacterizing mutational heterogeneity in a glioblastoma patient with double recurrence.B-FABP-expressing radial glial cells: the malignant glioma cell of origin?BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors.Intratumoral therapy of glioblastoma multiforme using genetically engineered transferrin for drug delivery.Mesenchymal migration as a therapeutic target in glioblastoma.Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiformeA tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme.Glioblastoma treatment patterns, survival, and healthcare resource use in real-world clinical practice in the USA.RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivoIntracranial MEMS based temozolomide delivery in a 9L rat gliosarcoma model.Rhenium-186 liposomes as convection-enhanced nanoparticle brachytherapy for treatment of glioblastoma.α-Carboline derivative TJY-16 inhibits tumor growth by inducing G2/M cell cycle arrest in glioma cells.Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRIComparative Analysis of Matrix Metalloproteinase Family Members Reveals That MMP9 Predicts Survival and Response to Temozolomide in Patients with Primary Glioblastoma.VB-111: a novel anti-vascular therapeutic for glioblastoma multiformeComprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomicsPhase II study of single-agent bevacizumab in Japanese patients with recurrent malignant glioma.Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity.Investigating molecular alterations to profile short- and long-term recurrence-free survival in patients with primary glioblastoma.Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicineReal-time multi-modality imaging of glioblastoma tumor resection and recurrence.Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomasGlioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approachesInfluence of enzyme-inducing antiepileptic drugs on trough level of imatinib in glioblastoma patients.Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience.A neurocentric perspective on glioma invasion.Nicotinic acid inhibits glioma invasion by facilitating Snail1 degradationInteraction of brain fatty acid-binding protein with the polyunsaturated fatty acid environment as a potential determinant of poor prognosis in malignant glioma.Long-Term Survival and Improved Quality of Life following Multiple Repeat Gamma Knife Radiosurgeries for Recurrent Glioblastoma Multiforme: A Case Report and Review of the Literature.Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme.Mechanisms regulating glioma invasion.Hypoxia in astrocytic tumors and implications for therapy.Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model.A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.
P2860
Q26800604-01A731B9-1423-4F91-A642-3CB540DE1B74Q27016552-5539186C-D42C-4EA3-853D-DCFD48F1968BQ28067135-B7E7287C-6867-4B3A-BCC0-8408822305E0Q30366921-7D469F79-3262-42A0-8FF4-F5AF0BCAA376Q30412393-B8606B2C-04D6-4A81-8807-C1587FD7B4A5Q30458838-810E95AD-DD5C-4F8B-9643-85BC2C97FD33Q30468306-008947CA-53D8-4C64-A73C-CF21E6FF10D6Q30480106-4674F5AA-BB0E-465F-93EA-05E601A4B773Q33528294-ECA9882C-EC85-41DC-A6C8-2B77326758C8Q33945802-097B2950-DE91-496C-B347-A0937614F856Q34002994-A8D2E013-BDF6-48EF-B07C-D5D32F3E0897Q35027024-B192EF5A-DDE1-4668-A765-865C87BCCD18Q35088396-829C06F0-E317-4EFF-8899-DAE18645A46CQ35222941-3DEC0660-4BB6-4F37-AB97-6384FB0BD0A9Q35225270-60B230AF-0418-4343-9C44-B554CFE31220Q35504426-53701B97-993E-4816-BB74-A020875B2441Q35845261-15154410-FC40-4146-8008-D57BEAD67997Q35898306-785257CE-6EFC-4374-9F5E-5F2871984354Q35946168-6E01CBBC-55F3-4AAC-84D4-55ADAE2E4E1BQ35972486-98E36F35-8B68-45AC-8A78-194129F6D81BQ36096024-AD4BD857-5A98-4C7F-BE26-29C63D8C7F22Q36104523-A09D6BD8-EC07-4D6B-994E-DED525BF76DAQ36251337-7618D4E0-5E52-4840-8E5C-DB59C2AB7698Q36291579-1C38C4B2-60E8-41B9-8B34-7F681A68585EQ36335681-D8765062-27B1-4E1D-A58A-F0C080CE315DQ36403289-90CAE0A6-C8A0-4C22-8C82-4B16F8C3ADECQ36543537-5FB3529F-7950-416D-974C-39621055EAC0Q37036905-36D73EB0-D03D-4EC7-811B-9D4DAA01D193Q37287987-6F5886F5-6F0C-440F-A84C-4B58F5211184Q37357178-F638014E-C7C6-4818-A34D-181DB7814D42Q37366417-37505F2F-CA24-497D-B2C7-AE0FAFAF2B2FQ37638128-D193C462-D19B-4E39-9171-78150725CC8AQ37679063-D55BD254-596C-4041-A57F-9D4A8CA77D60Q38131891-7EC9FF3C-2B72-4F8C-B51D-F008BEBECD38Q38156790-3222A4D3-AF71-4F92-9B0C-E519B10C7536Q38245925-ABAAA1B9-D8B3-4A31-B676-90842B71226CQ38386429-BBF0FCEB-825F-4DC4-A288-C12CAB7E49D1Q38533276-66E31FFB-1F7E-4F0F-B17E-F26E7777A907Q38764607-0A56C115-2964-4D21-B18A-C75608F2712EQ38830917-D1EC6AB0-4DAC-4465-B3B7-4009A2065335
P2860
Recurrent glioblastoma multiforme: a review of natural history and management options.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Recurrent glioblastoma multiforme: a review of natural history and management options.
@ast
Recurrent glioblastoma multiforme: a review of natural history and management options.
@en
type
label
Recurrent glioblastoma multiforme: a review of natural history and management options.
@ast
Recurrent glioblastoma multiforme: a review of natural history and management options.
@en
prefLabel
Recurrent glioblastoma multiforme: a review of natural history and management options.
@ast
Recurrent glioblastoma multiforme: a review of natural history and management options.
@en
P2093
P356
P1433
P1476
Recurrent glioblastoma multiforme: a review of natural history and management options.
@en
P2093
Anand Veeravagu
Andrew R Hsu
Lewis C Hou
Victor C K Tse
P356
10.3171/FOC.2006.20.4.2
P577
2006-04-15T00:00:00Z